News

23 10, 2024

American Assoc. of Pharmaceutical Scientists (AAPS) PharmSci 360 Meeting – 2024

2025-03-14T18:53:33+00:00

Avance Biosciences™ offers top-tier GLP & GMP compliant services in assay development, validation, & sample testing for biopharma. Visit our booth to explore how we support drug discovery, development, & manufacturing with precision & expertise. [...]

American Assoc. of Pharmaceutical Scientists (AAPS) PharmSci 360 Meeting – 20242025-03-14T18:53:33+00:00
15 10, 2024

Immunogenicity & Bioassay Summit – 2024

2025-03-14T18:54:55+00:00

Avance Biosciences is excited to announce its participation in the upcoming Immunogenicity & Bioassay Summit, taking place from October 15-18, 2024, in Washington, DC. As the premier immunogenicity and bioassay event in the U.S., this summit provides an excellent platform for us to connect with industry [...]

Immunogenicity & Bioassay Summit – 20242025-03-14T18:54:55+00:00
17 09, 2024

CRISPR-Based Therapy Analytical Development Summit – 2024

2025-03-14T18:57:34+00:00

Avance Biosciences is excited to announce its participation in the upcoming 2nd CRISPR-Based Therapy Analytical Development Summit, taking place from September 17-19, 2024, in Boston, MA. This premier event is a key gathering for professionals and innovators in the gene editing and CRISPR fields.[...]

CRISPR-Based Therapy Analytical Development Summit – 20242025-03-14T18:57:34+00:00
20 08, 2024

World’s first gene editing therapy for blood disorder to be available to hundreds of patients in England

2024-08-20T13:52:29+00:00

Patients in England with severe beta-thalassaemia will be amongst the first in Europe to benefit from one-time gene therapy exagamglogene autotemcel. Exa-cel is the world’s first CRISPR-based gene therapy and the first gene therapy available in Europe for treating severe beta-thalassaemia...

World’s first gene editing therapy for blood disorder to be available to hundreds of patients in England2024-08-20T13:52:29+00:00
6 08, 2024

FDA Approves First T Cell Receptor (TCR) Gene Therapy

2024-08-06T19:21:42+00:00

Tecelra is the first FDA-approved T cell receptor (TCR) gene therapy. The product is an autologous T cell immunotherapy composed of a patient’s own T cells. T cells in Tecelra are modified to express a TCR that targets MAGE-A4, an antigen expressed by cancer cells in synovial sarcoma...

FDA Approves First T Cell Receptor (TCR) Gene Therapy2024-08-06T19:21:42+00:00
31 07, 2024

Shortening FDA-Mandated CAR T-Cell Therapy Monitoring Periods Could Improve Access to Treatment in Patients With DLBCL

2024-07-31T13:47:53+00:00

Two hallmark toxicities of chimeric antigen receptor (CAR) T-cell therapy may be rare after 2 weeks following infusion in patients with diffuse large B-cell lymphoma (DLBCL), supporting a shorter, more flexible toxicity monitoring period, according to a recent study...

Shortening FDA-Mandated CAR T-Cell Therapy Monitoring Periods Could Improve Access to Treatment in Patients With DLBCL2024-07-31T13:47:53+00:00
13 05, 2024

American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 2024

2025-03-14T18:59:26+00:00

Avance Biosciences™ offers top-tier GLP & GMP compliant services in assay development, validation, & sample testing for biopharma. Visit our booth to explore how we support drug discovery, development, & manufacturing with precision & expertise. [...]

American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 20242025-03-14T18:59:26+00:00
7 05, 2024

American Society of Gene and Cell Therapy (ASGCT) Conference – 2024

2025-03-14T19:17:52+00:00

Avance Biosciences™ is excited to announce our participation in the American Society of Gene & Cell Therapy (ASGCT) conference, where we’ll be showcasing our advanced services and expertise to propel the future of gene and cell therapy. [...]

American Society of Gene and Cell Therapy (ASGCT) Conference – 20242025-03-14T19:17:52+00:00
6 05, 2024

Workshops on Recent Issues in Bioanalysis (WRIB) Conference – 2024

2025-03-14T19:20:41+00:00

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

Workshops on Recent Issues in Bioanalysis (WRIB) Conference – 20242025-03-14T19:20:41+00:00
Go to Top